Traws Pharma (TRAW) Tops Q1 EPS by 209c

Traws Pharma (NASDAQ: TRAW) reported Q1 EPS of $2.09. Revenue for the quarter came in at $60 thousand.

For earnings history and earnings-related data on Traws Pharma (TRAW) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Morgan Stanley cuts China property forecasts on deeper price drops
• INVO Fertility (IVF) Tops Q2 EPS by 105c